Cardiovascular Research
Investigators at University of Warsaw Release New Data on Cardiovascular Research
Published in Cardiovascular Week, December 26th, 2011
2011 DEC 26 -- Data detailed in "Silymarin inhibits endothelial progenitor cells' senescence and protects against the antiproliferative activity of rapamycin: preliminary study" have been presented. According to the authors of recent research published in the Journal of Cardiovascular Pharmacology, "Rapamycin, an antiproliferative agent used on drug-eluting stents, induces endothelial progenitor cells (EPCs) senescence through telomerase inactivation and may impair the reendothelization of an injured arterial wall, leading to thrombosis. We examined whether silymarin, a complex of flavonolignans with hepatoprotective and antioxidative properties, can protect EPCs...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Week
Source: Cardiovascular Week (2011-12-26)
More Articles from Cardiovascular Week
- Cardiovascular Research
Cardiovascular Toxicology - Oxidoreductases
Findings from University of Washington in Oxidoreductases Reported - Ventricular Tachycardia
Investigators at University Hosp Publish Research in Ventricular Tachycardia - Cardiology
New Cardiology Research Has Been Reported by Investigators at Boehringer Ingelheim - Cardiovascular Research
New Cardiovascular Research Research from Pharmacology Research Laboratories Outlined - Cardiovascular Research
New Cardiovascular Research Study Findings Have Been Reported from Sapporo Medical University - More from this issue of Cardiovascular Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
